Tenax Therapeutics

IPO

Tenax

Tenax Therapeutics was founded in 1967, is headquartered in Chapel Hill, United States, lists 1–10 employees, and has $125.0M in recorded funding across 2 rounds.

Employees
1–10
Founded
1967
Business Model
B2B
Total Funding
$125.0M
Last Round
$25.0M Corporate RoundMar 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Tenax Therapeutics is a Phase 3 specialty pharmaceutical company focused on identifying, developing, and commercializing novel therapies for cardiopulmonary diseases including pulmonary arterial hypertension and heart failure. The company leverages clinical insights into pulmonary and cardiovascular disorders to advance its pipeline of treatments for patients with unmet medical needs.

Summary

Tenax Therapeutics is a Biotech company based in Chapel Hill, United States, founded in 1967. It lists 1–10 employees. It has raised $125.0M in total across 2 rounds, most recently a $25.0M Corporate Round in Mar 2025. Investors include RTW Investments.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2025
$25.0M

Sign up to see all 2 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tenax Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tenax-therapeutics"><img src="https://indexed.vc/api/badge/company/tenax-therapeutics" alt="Tenax Therapeutics on Indexed.vc" width="260" height="76" /></a>